Areas of interest

We build on our internal expertise, transforming breakthrough science into effective medicine.

Our key focus areas


As leading experts in autoimmune diseases and therapies, AbbVie is focused on developing new medicines to address chronic progressive diseases in the field of immunology. Our programs focus on investigating both targeted oral therapies and biologics. Our areas of interest include:

  • Crohn’s disease, ulcerative colitis
  • Psoriasis, atopic dermatitis
  • Rheumatology (RA, PsA, SpA)
  • Novel therapies for SLE, systemic sclerosis, Sjogrens syndrome
  • Fibrotic conditions associated with certain inflammatory conditions


Our research is committed to advancing drug candidates that hold the potential to transform standard of care for patients with severe and life-threatening diseases. AbbVie seeks to further expand its oncology portfolio in strategically prioritized areas with externally-sourced compounds from academic and industrial collaborators. Our areas of interest include:

  • Solid tumors and hematologic malignancies
  • Targeted therapies for regulated cell death, B-cell signaling, immuno-oncology
  • Next generations of targeted small molecules
  • Novel targeted biologics
  • New T-cell-engaging- and T-cell receptor-based approaches


Our innovative research focuses on developing therapies for neurodegenerative diseases by targeting mechanisms that prevent neurodegeneration and promote neuroprotection. We are interested in drug targets, early and late stage assets, biomarkers and technologies. We prioritize first-in-class assets, or those that are clearly differentiated versus existing and emerging therapies. Our areas of interest include:

  • Alzheimer’s disease
  • Parkinson’s disease
  • Other neurodegenerative diseases that share proteinopathy mechanisms with AD and PD
  • Multiple sclerosis

Additional focus areas

We also selectively focus our attention on other areas where there is unmet need:

  • Cystic fibrosis
  • Women’s health
  • Virology
  • Platforms and technologies


For more information about partnering with AbbVie, download our brochure.